Wells Fargo
IMA

Wells Fargo’s ImageneBio Inc IMA Stock Holding History

Wells Fargo’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-41
Closed -$205 – 7440
2026
Q1 		$205 Hold
41
– – ﹤0.01% 6459
2025
Q4 		$283 Hold
41
– – ﹤0.01% 6368
2025
Q3 		$334 Sell
41
-1
-2% -$13 ﹤0.01% 6321
2025
Q2 		$670 Buy
+42
New +$617 ﹤0.01% 6350
2024
Q2 		– Sell
-907
Closed -$15.4K – 7154
2024
Q1 		$15.4K Buy
907
+117
+15% +$2.13K ﹤0.01% 5644
2023
Q4 		$18.7K Buy
790
+279
+55% +$9.1K ﹤0.01% 5659
2023
Q3 		$26.5K Sell
511
-175
-26% -$10.5K ﹤0.01% 5480
2023
Q2 		$54K Buy
686
+663
+2,883% +$47.5K ﹤0.01% 5396
2023
Q1 		$942 Hold
23
– – ﹤0.01% 6399
2022
Q4 		$718 Buy
23
+1
+5% +$32 ﹤0.01% 6285
2022
Q3 		$1K Buy
22
+8
+57% +$463 ﹤0.01% 6364
2022
Q2 		$0 Sell
14
-243
-95% -$13.4K ﹤0.01% 7106
2022
Q1 		$19K Sell
257
-960
-79% -$102K ﹤0.01% 6030
2021
Q4 		$184K Buy
1,217
+32
+3% +$5.19K ﹤0.01% 5310
2021
Q3 		$180K Buy
1,185
+834
+238% +$121K ﹤0.01% 5143
2021
Q2 		$59K Buy
+351
New +$77.4K ﹤0.01% 5494

Other funds holding IMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Wells Fargo's IMA Position: Q2 2026 in Review

Wells Fargo sold out of ImageneBio Inc (IMA) in Q2 2026, closing a stake of 41 shares — an estimated $205 sold.

Wells Fargo first reported a position in IMA in Q2 2021 and held it in 16 quarters. The position peaked at $184K in Q4 2021. 35 funds tracked by Wall St. Rank hold IMA as of Q2 2026.

  • Wells Fargo reported no remaining ImageneBio Inc position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 41 ImageneBio Inc shares in Q2 2026, an estimated $205.
  • Wells Fargo first reported a position in ImageneBio Inc in Q2 2021 and held it in 16 quarters.
  • Wells Fargo's ImageneBio Inc position peaked at $184K in Q4 2021.
  • 35 funds tracked by Wall St. Rank held ImageneBio Inc as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.